Dianthus Therapeutics | MGTA - EPS Earnings Per Share


Dianthus Therapeutics reported $-0.85 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Avita Medical AUD -0.38 0 Dec/2025
Celltrion KRW 1.35K 224.25 Jun/2026
Cspc Pharmaceutical CNY 0.08 0.08 Mar/2026
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -0.85 0.58 Mar/2026
Divis Laboratories Ltd INR 24.02 4.27 Jun/2026
IQVIA Holdings USD 3.15 0.25 Jun/2026
Kangmei Pharma CNY 0 0 Mar/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Moderna USD -1.97 1.43 Jun/2026
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organigram Holdings CAD -0.01 0.15 Mar/2026
Organon & Co USD 0.4 0.31 Jun/2026
Ovoca Bio EUR 0 0.06 Dec/2025
Pharma Mar EUR 0.16 0.07 Jun/2026
Qiagen NV USD 0.54 0.08 Jun/2026
Revvity USD 1.41 0.35 Jun/2026
Sartorius EUR 0.95 0.25 Jun/2026
Sino Biopharmaceutical CNY 0.19 0.25 Jun/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.69 0.1 Jun/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026
Zealand Pharma A/S -5.58 2.76 Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 0.97 0.27 Jun/2026